News

29.02.16

Two-thirds of cancer drugs could be lost under changes to fund – ABPI

Leading pharmaceutical representatives say that the decision to take away the heavily-criticised Cancer Drugs Fund (CDF’s) power to prescribe drugs without NICE’s approval could mean two-thirds of medicines will no longer be available.

The Association of the British Pharmaceutical Industry (ABPI) warned that the proposed changes do not go far enough and would significantly set back patient care.

The announcement came following a Public Accounts Committee report which criticised the CDF for cutting across the work of NICE and mismanaging its funds to the point that costs grew by 138% in the period 2013-15.

Dr Paul Catchpole, value and access director at the ABPI, said he was disappointed by the decision and that NHS England “will continue to push ahead with largely unchanged proposals for a new Cancer Drugs Fund”.

“This carries the very real risk of significantly setting back patient access to cancer medicines, now and for the foreseeable future,” he said.

 ​​​"If cancer medicines go through more or less exactly the same NICE appraisal process that was in place five years ago - which necessitated the setting up of the CDF in the first place - we will largely get the same answers as before - the majority of medicines will be turned down. Turning the clock back five years just doesn't make sense; substantial change is needed to the way that NICE appraisers cancer medicines to prevent this.

"We also need less draconian financial controls. It is unreasonable for companies to be expected to underwrite 100% of the financial risk in managing the CDF budget, something which is outside of their individual control.

"Without substantial changes, the ABPI estimates that under the proposals two thirds of existing CDF medicines are likely to no longer be available to NHS patients by the end of the year. This is in addition to patients who are already waiting for access to around 10 new cancer medicines which have been launched since the Fund was closed to new applications in May 2015.”

Last year the financially-strapped CDF stopped funding 25 treatments for cancer, a decision that led the ABPI to call the CDF “a sticking plaster”.

The National Audit Office warned in September that the CDF was no longer sustainable.

Comments

There are no comments. Why not be the first?

Add your comment

national health executive tv

more videos >

latest news

View all News

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental ... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Bei... more >

editor's comment

26/06/2020Adapting and Innovating

Matt Roberts, National Health Executive Editorial Lead. NHE May/June 2020 Edition We’ve been through so much as a health sector and a society in recent months with coronavirus and nothing can take away from the loss and difficulties that we’ve faced but it vital we also don’t disregard the amazing efforts we’ve witnessed. Staff have gone above and beyond, whole hospitals and trusts have flexed virtually at will to meet demand and pressures and we’ve... read more >

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us throu more > more last word articles >

interviews

Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

24/10/2019Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

Today, speaking at the Royal College of General Practitioners (RCGP) annual... more >

the scalpel's daily blog

Covid-19 can signal a new deal with the public on health

28/08/2020Covid-19 can signal a new deal with the public on health

Danny Mortimer, Chief Executive, NHS Employers & Deputy Chief Executive, NHS Confederation The common enemy of coronavirus united the public side by side wi... more >
read more blog posts from 'the scalpel' >

healthcare events

events calendar

back

September 2020

forward
mon tue wed thu fri sat sun
31 1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 1 2 3 4
5 6 7 8 9 10 11

featured articles

View all News